Pre-surgery coaching can reduce cost, length of stay

Running a marathon takes weeks of preparation of the mind and body—and researchers are investigating a similar approach, if less intense, to patients before surgery. A study, published by Surgery, found that basic wellness and fitness coaching can cut costs and the patient's length of stay.

The study examined the effectiveness of the Michigan Surgical and Health Optimization Program (MSHOP), a program focused on mentally and physically strengthening the patient before surgery, in saving hospitals money and shortening a patient’s stay.

"We do a lot in medicine to get people ready for surgery, but they're primarily administrative tasks—checking off boxes that don't necessarily make a patient better," said Michael Englesbe, MD, a University of Michigan transplant surgeon. "The more you can do to manage your status preoperatively, the quicker you'll be able to bounce back."

Conducted by Englesbe and Stewart Wang, MD, PhD, the program included daily automated phone reminders to improve diet, reduce stress and engage in breathing exercises and physical activity. A total of 641 patients underwent surgeries including liver, gastrointestinal, pancreas, thoracic, organ transplants and an esophageal resection.

Results found that those who participated in MSHOP to cut their hospital length of stay from an average of seven days to five and cut costs by 30 percent.

"Patients don't care about costs or how long they're going to be in the hospital. They just want to get through the experience," said Englesbe. "This is an empowering tool that helps them do something positive in the face of a very negative event. Once it's a billable service, it will really take off.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.